Bolden Therapeutics
PrivateLast Round
Pre Seed
Jan 17, 2024
Total Funding Raised
$2.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bolden Therapeutics is a biotechnology company that develops first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system illnesses such as Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bolden Therapeutics Comparables
Compare Bolden Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leal Therapeutics | 82% | |
| Ionis Pharmaceuticals, Inc. | 70% | |
| QurAlis | 69% |
Bolden Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 17, 2024 | ||||
| Grant | Sep 16, 2022 | ||||
| Grant | Jun 29, 2022 | ||||
| Grant | Sep 27, 2021 |
Bolden Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Resolute Venture Partners | Pre Seed |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| Resolute Ventures | Pre Seed |
| LifeSpan Vision Ventures | Pre Seed |
| Slater Technology Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 183% MoM.
- May 18, 2026
Monthly visitors increased 135% MoM, reaching 836.
Bolden Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bolden Therapeutics's valuation, stock price, and market status.
Is Bolden Therapeutics a public or private company?
Bolden Therapeutics is a private company.
What is the current stock price of Bolden Therapeutics?
Bolden Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Bolden Therapeutics worth (valuation)?
Valuation information for Bolden Therapeutics is not publicly available.
Can I buy Bolden Therapeutics stock?
Bolden Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bolden Therapeutics's last funding round?
Funding round information for Bolden Therapeutics is not publicly available.
Who are the main investors in Bolden Therapeutics?
Investor information for Bolden Therapeutics is not publicly disclosed.
Will Bolden Therapeutics IPO soon?
No public IPO plans have been announced for Bolden Therapeutics.
How can I track Bolden Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bolden Therapeutics's secondary market activity and sign up for updates.